Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback